These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2100733)

  • 21. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of fluconazole resistance using Chrom agar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
    Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparations of liposomal fluconazole and their in vitro antifungal activity.
    Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
    J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antifungal activity of fluconazole in vitro].
    Pawlik B; Macura AB
    Med Dosw Mikrobiol; 1995; 47(1-2):101-6. PubMed ID: 8523965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
    Arévalo MP; Arias A; Andreu A; Rodríguez C; Sierra A
    J Chemother; 1994 Aug; 6(4):226-9. PubMed ID: 7830098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Wardle HM; Law D; Moore CB; Mason C; Denning DW
    Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis.
    Siqueira AB; Rodriguez LR; Santos RK; Marinho RR; Abreu S; Peixoto RF; Gurgel BC
    Braz Oral Res; 2015; 29():. PubMed ID: 26154370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D; Barchiesi F; Ancarani F; Scalise G
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates.
    Palacín C; Tarragó C; Agut J; Guglietta A
    Methods Find Exp Clin Pharmacol; 2001 Mar; 23(2):61-4. PubMed ID: 11484411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole.
    Cooper CR; McGinnis MR
    Am J Obstet Gynecol; 1996 Dec; 175(6):1626-31. PubMed ID: 8987951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of a breakpoint test for determination of fluconazole susceptibility of yeasts].
    Fegeler W
    Mycoses; 1997; 40 Suppl 1():47-52. PubMed ID: 9417513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
    Ozkan S; Kaynak F; Kalkanci A; Abbasoglu U; Kustimur S
    Mem Inst Oswaldo Cruz; 2005 May; 100(3):319-23. PubMed ID: 16113876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.